Boule Diagnostics AB Cash Flow Conversion Efficiency

Latest as of June 2025: -0.017x

Boule Diagnostics AB cash flow conversion efficiency. Based on the latest financial reports, Boule Diagnostics AB (BOUL) has a cash flow conversion efficiency ratio of -0.017x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.70 Million ≈ $-290.56K USD) by net assets (Skr161.50 Million ≈ $17.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Boule Diagnostics AB (2005–2024)

Cash flow conversion efficiency of Boule Diagnostics AB from 2005 to 2024. This chart illustrates how Boule Diagnostics AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Boule Diagnostics AB for real-time trading data and today's change.

Boule Diagnostics AB Cash Flow Conversion Ratio Explained

Boule Diagnostics AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Boule Diagnostics AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boule Diagnostics AB ranked by their cash flow conversion efficiency. Also see BOUL market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Caledonia Mining Corporation Plc
LSE:CMCL
0.050x
Qlife Holding AB
ST:QLIFE
-2.207x
Maxeon Solar Technologies Ltd
NASDAQ:MAXN
0.148x
Opawica Explorations Inc
V:OPW
-0.022x
XORTX Therapeutics Inc
V:XRTX
-0.319x
BELLUSCURA PLC LS -01
F:9VQ
N/A
Sure-Tech Investments LP
TA:STEC
-0.038x
Ibstock PLC
LSE:IBST
0.026x

Annual Cash Flow Conversion Efficiency for Boule Diagnostics AB (2005–2024)

The table below shows the annual cash flow conversion efficiency of Boule Diagnostics AB from 2005 to 2024. Review Boule Diagnostics AB free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr269.60 Million
≈ $29.01 Million
Skr46.60 Million
≈ $5.01 Million
0.173x +59.84%
2023-12-31 Skr475.10 Million
≈ $51.13 Million
Skr51.38 Million
≈ $5.53 Million
0.108x +540.55%
2022-12-31 Skr462.50 Million
≈ $49.77 Million
Skr-11.35 Million
≈ $-1.22 Million
-0.025x -116.77%
2021-12-31 Skr295.74 Million
≈ $31.83 Million
Skr43.28 Million
≈ $4.66 Million
0.146x -47.61%
2020-12-31 Skr269.30 Million
≈ $28.98 Million
Skr75.24 Million
≈ $8.10 Million
0.279x +72.30%
2019-12-31 Skr332.87 Million
≈ $35.82 Million
Skr53.98 Million
≈ $5.81 Million
0.162x +115.26%
2018-12-31 Skr300.86 Million
≈ $32.38 Million
Skr22.66 Million
≈ $2.44 Million
0.075x -65.83%
2017-12-31 Skr261.77 Million
≈ $28.17 Million
Skr57.72 Million
≈ $6.21 Million
0.220x +154.89%
2016-12-31 Skr229.76 Million
≈ $24.73 Million
Skr19.88 Million
≈ $2.14 Million
0.087x -26.95%
2015-12-31 Skr188.51 Million
≈ $20.29 Million
Skr22.32 Million
≈ $2.40 Million
0.118x -35.03%
2014-12-31 Skr169.99 Million
≈ $18.29 Million
Skr30.98 Million
≈ $3.33 Million
0.182x +48.25%
2013-12-31 Skr127.49 Million
≈ $13.72 Million
Skr15.68 Million
≈ $1.69 Million
0.123x +124.26%
2012-12-31 Skr199.69 Million
≈ $21.49 Million
Skr10.95 Million
≈ $1.18 Million
0.055x +94.22%
2011-12-31 Skr192.86 Million
≈ $20.75 Million
Skr5.44 Million
≈ $585.86K
0.028x -77.19%
2010-12-31 Skr130.56 Million
≈ $14.05 Million
Skr16.16 Million
≈ $1.74 Million
0.124x +52.21%
2009-12-31 Skr100.89 Million
≈ $10.86 Million
Skr8.20 Million
≈ $882.84K
0.081x +117.31%
2008-12-31 Skr115.22 Million
≈ $12.40 Million
Skr4.31 Million
≈ $463.92K
0.037x -78.30%
2005-12-31 Skr132.36 Million
≈ $14.24 Million
Skr22.82 Million
≈ $2.46 Million
0.172x --

About Boule Diagnostics AB

ST:BOUL Sweden Medical Devices
Market Cap
$3.55 Million
Skr33.01 Million SEK
Market Cap Rank
#29170 Global
#655 in Sweden
Share Price
Skr0.85
Change (1 day)
-15.00%
52-Week Range
Skr0.85 - Skr6.30
All Time High
Skr74.05
About

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clini… Read more